ASX Announcements

Notice under section 708A(5)(e) of the Corporations Act
Appendix 3B
Neuren announces investment and exclusive negotiation period
Notice of Annual General Meeting/Proxy Form
Appendix 4G
Annual Report to shareholders
Appendix 4C - quarterly
First patent in Japan granted for Neuren's trofinetide
Full Year Statutory Accounts
Disclosure under Listing Rule 4.3D